Literature DB >> 30662796

Epigenetic regulation of alternative splicing.

Li-Yuan Zhu1, Yi-Ran Zhu1, Dong-Jun Dai2, Xian Wang2, Hong-Chuan Jin1.   

Abstract

Alternative splicing (AS) serves as an additional regulatory process for gene expression after transcription, and it generates distinct mRNA species, and even noncoding RNAs (ncRNAs), from one primary transcript. Generally, AS can be coupled with transcription and subjected to epigenetic regulation, such as DNA methylation and histone modifications. In addition, ncRNAs, especially long noncoding RNAs (lncRNAs), can be generated from AS and function as splicing factors ("interactors" or "hijackers") in AS. Recently, RNA modifications, such as the RNA N6-methyladenosine (m6A) modification, have been found to regulate AS. In this review, we summarize recent achievements related to the epigenetic regulation of AS.

Entities:  

Keywords:  Alternative splicing; epigenetic regulation; lncRNAs; m6A modification

Year:  2018        PMID: 30662796      PMCID: PMC6325479     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  29 in total

Review 1.  Alternative splicing of lncRNAs in human diseases.

Authors:  Jiaxi Chen; Yawen Liu; Jingyu Min; Huizhi Wang; Feifan Li; Chunhui Xu; Aihua Gong; Min Xu
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Long noncoding RNA DLX6-AS1 targets miR-124-3p/CDK4 to accelerate Ewing's sarcoma.

Authors:  Xiaomei Lei; Siping Yang; Yuanyuan Yang; Juan Zhang; Yue Wang; Minhui Cao
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

Review 3.  Non-Coding RNA Networks as Potential Novel Biomarker and Therapeutic Target for Sepsis and Sepsis-Related Multi-Organ Failure.

Authors:  Domenico Di Raimondo; Edoardo Pirera; Giuliana Rizzo; Irene Simonetta; Gaia Musiari; Antonino Tuttolomondo
Journal:  Diagnostics (Basel)       Date:  2022-05-31

4.  Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma.

Authors:  Guangyao Bao; Tian Li; Xiaojiao Guan; Yao Yao; Jie Liang; Yifan Xiang; Xinwen Zhong
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

Review 5.  Alternative Splicing of ALS Genes: Misregulation and Potential Therapies.

Authors:  Benedetta Perrone; Valentina La Cognata; Teresa Sprovieri; Carmine Ungaro; Francesca Luisa Conforti; Sebastiano Andò; Sebastiano Cavallaro
Journal:  Cell Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.046

Review 6.  RNA methylation in chloroplasts or mitochondria in plants.

Authors:  Stefano Manduzio; Hunseung Kang
Journal:  RNA Biol       Date:  2021-04-05       Impact factor: 4.652

7.  Cassava AGPase genes and their encoded proteins are different from those of other plants.

Authors:  Ming-You Dong; Xian-Wei Fan; You-Zhi Li
Journal:  Planta       Date:  2019-08-09       Impact factor: 4.540

8.  Expression of colorectal neoplasia differentially expressed in anaplastic thyroid carcinoma and its effect on cancer cell proliferation.

Authors:  Lili Du; Qingsong Zhao; Jingjing Li; Mingli Wang; Hong Qiao
Journal:  Ann Transl Med       Date:  2022-04

Review 9.  Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation.

Authors:  Zhihui Dou; Dapeng Zhao; Xiaohua Chen; Caipeng Xu; Xiaodong Jin; Xuetian Zhang; Yupei Wang; Xiaodong Xie; Qiang Li; Cuixia Di; Hong Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-06-12

10.  Full-length transcriptome analysis reveals the mechanism of acupuncture at PC6 improves cardiac function in myocardial ischemia model.

Authors:  Jing Yuan; Jun-Meng Wang; Zhi-Wei Li; Cheng-Shun Zhang; Bin Cheng; Su-Hao Yang; Bai-Tong Liu; Li-Juan Zhu; Ding-Jun Cai; Shu-Guang Yu
Journal:  Chin Med       Date:  2021-07-08       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.